Full-spectrum proxy consent for research participation when persons with Alzheimer disease lose decisional capacities: Research ethics and the common good

Alzheimer Disease and Associated Disorders

Volumn 17, Issue SUPPL. 1, 2003, Pages

  Post, Stephen G ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer disease; Ethics; Maximal risk; Nontherapeutic; Proxy consent; Research

Indexed keywords

ALZHEIMER DISEASE; CLINICAL RESEARCH; COMPETENCE; CONFERENCE PAPER; CUSTODY; DECISION MAKING; HUMAN; INFORMED CONSENT; MEDICAL ETHICS; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0037732816     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-200304001-00002     Document Type: Conference Paper

References (15)

1. Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. JAMA 1989;262:2551-6.
2. Aevarsson O, Skoog I. A population-based study on the incidence of dementia disorders between 85 and 88 years of age. J Am Geriatr Soc 1996;44:1455-60.
3. Evans DA, Scherr PA, Cook NR, et al. Estimated prevalence of Alzheimer's disease in the United States. Milbank Q 1990;68:267-89.
4. Gladwell M. The Alzheimer's strain: how to accomodate too many patients. New Yorker 1997; October 20,27:125-7.
5. Rice DP, Fox PJ, Max W, et al. The economic burden of Alzeheimer's disease care. Health Affairs 1993;12:164-76.
6. Cahill M, Wichman A. Research involving persons with cognitive impairments: results of a survey of Alzeheimer Disease Research Centers in the United States. Alzheimer Dis Assoc Disord 2000;14:20-7.
7. National Bioethics Advisory Commission. Research Involving Persons with Mental Disorders That May Affect Decisionmaking Capacity. Vol. 1. Report and Recommendations Rockville, MD: National Bioethics Advisory Commission, 1998.
8. American College of Physicians. Cognitively impaired subjects. Ann Intern Med 1989;111:843-8.
9. Post SG. Why the tolerance of potential harms? Research ethics in Alzheimer disease. Accountability Res 1999;7:241-53.
10. Keyserlingk EW, Glass KC, Kogan S, Gauthier S. Proposed guidelines for the participation of persons with dementia as research subjects. Perspect Biol Med 1995;38:319-62.
11. High DM, Whitehouse PJ, Post SG, Berg L. Guidelines for addressing ethical and legal issues in Alzheimer disease research: a position paper." Alzheimer Dis Assoc Disord 1994; 8(Suppl 4):66-74.
12. Emanuel EF, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000;283:2701-11.
13. McCorrnick RA. Proxy consent in the experimentation situation. Perspect Biol Med 1974;18:2-20; reprinted in McCormick RA, How Brave a New World? Dilemmas in Bioethics New York: Doubleday, 1981:51-71.
14. McCorrnick RA. Proxy consent in the experimentation situation. Perspect Biol Med 1974;18:2-20; reprinted in McCormick RA, How Brave a New World? Dilemmas in Bioethics New York: Doubleday, 1981:51-71.
15. Weijer C. Thinking clearly about research risk: implications of the work of Benjamin Freedman. IRB: A Review of Human Subjects 1999;21:1-5.